Artelo Biosciences

Ammortal is a healthcare services company that offers bio-optimization services.

Omniox is a biopharmaceutical company developing new medicines for hypoxic diseases. Hypoxia, defined as insufficient levels of oxygen in tissues, is known to trigger or impact a range of serious illnesses and conditions including many cancers, cardiovascular diseases, and trauma. At the center of Omniox’ work is a protein-based platform technology (H-NOX), that is engineered to reverse hypoxic disease states by delivering oxygen or nitric oxide preferentially to hypoxic tissues.

Swaza develops nanotechnology-based therapeutics designed to address critical medical conditions involving impaired oxygen delivery and tissue healing. The company focuses on a nanofluid breathing aid, AeroHeal, which delivers oxygen and removes carbon dioxide in patients with compromised lungs, eliminating the need for invasive ventilation. Their primary product, SWAZA-1, is a non-invasive nanofluid that facilitates gas exchange in damaged lungs. Additionally, SWAZA-2 is an oxygen-enriched biomaterial aimed at enhancing wound healing, and SWAZA-3 is a thermoreversible enema intended for emergency oxygenation.

A cell therapy business called Immusoft is dedicated to creating revolutionary treatments for uncommon diseases by leveraging sustained delivery of therapeutic proteins from a patient's own cells. Immune System Programming (ISPTM), a technology platform being developed by the company, alters a patient's B cells and teaches them to create gene-encoded medications. The ISP-reprogrammed B cells develop into tiny drug factories that are anticipated to live in patients for many years and give therapeutic effect. The business is based in Seattle, Washington.

Defeat the mutants.

Zenas BioPharma is a company based in Florida, USA that specializes in creating immune-focused treatments for patients.

Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant.

OnKure is committed to the discovery and development of best-in-class precision medicines that target biologically validated drivers of #cancer.

Apogee Therapeutics, a biotechnology company headquartered in San Francisco, California, was established in 2022 with a focus on developing innovative therapies for immunological and inflammatory conditions to meet the needs of patients.

Rybodyn is a biotechnology research company that develops therapeutics to train the immune system to detect and eradicate cancer internally.

Turn Therapeutics is a pharmaceutical company that is dedicated to reducing the human and economic costs of infection and skin disease. Turn Therapeutics was founded to reduce antibiotic resistance through best-in-class acute and chronic wound care products. The company's mission is to leverage expertise in drug delivery to create disruptive products for high need indications. GLOBAL HEALTH SOLUTIONS, INC. , dba Turn Therapeutics.